APhA Questions

APhA Questions Under the direction of the U.S. Department of Health and Human Services, the Healthy People initiative has identified the following as a goal for 2030: - ANSWER-Increase the proportion of persons who are vaccinated annually against seasonal influenza The National Vaccine Advisory Committee 2013 Standards for Adult Immunization Practice and the 2016 International Pharmaceutical Federation global report identify pharmacists as: - ANSWER-Integral to increasing vaccination rates Opportunities for Advocacy and Collaboration include: - ANSWER-Membership in state immunization coalition to serve as an expert on policy and practice issues affecting pharmacy Which of the following is one of the five guidelines identified by the APhA Board of Trustees in 2019 to assist pharmacists in incorporating immunization activities into their practice? - ANSWER-Prevention Which of the following diseases have been eradicated worldwide, allowing vaccination to be discontinued? - ANSWER-Smallpox Which of the following statements is false regarding polysaccharide and conjugated vaccines? - ANSWER-The conjugate protein used, such as diphtheria, can also provide adequate protection against itself in addition to the polysaccharide Which of the following vaccines listed is a live attenuated vaccine? - ANSWER-Varicella (VAR) When administering measles, mumps, rubella (MMR) and pneumococcal conjugate vaccine (PCV13) to a patient at their 15-month appointment, what must be considered regarding vaccine spacing? - ANSWER-MMR and PCV14 may be administered simultaneously or at any interval between doses Which vaccine technology listed below is an ingredient added typically to inactivated vaccines to boost its immune response by targeting pathogen recognition receptors that are expressed on dendritic cells to trigger a pro-inflammatory response? Though this technology creates a more robust immune response,